These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18029124)

  • 21. Combating substance abuse with ibogaine: pre- and posttreatment recommendations and an example of successive model fitting analyses.
    Hittner JB; Quello SB
    J Psychoactive Drugs; 2004 Jun; 36(2):191-9. PubMed ID: 15369200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine.
    Malcolm BJ; Polanco M; Barsuglia JP
    J Psychoactive Drugs; 2018; 50(3):256-265. PubMed ID: 29608409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic literature review of clinical trials and therapeutic applications of ibogaine.
    Köck P; Froelich K; Walter M; Lang U; Dürsteler KM
    J Subst Abuse Treat; 2022 Jul; 138():108717. PubMed ID: 35012793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ibogaine and the inhibition of acetylcholinesterase.
    Alper K; Reith ME; Sershen H
    J Ethnopharmacol; 2012 Feb; 139(3):879-82. PubMed ID: 22200647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating drug dependence with the aid of ibogaine: a retrospective study.
    Schenberg EE; de Castro Comis MA; Chaves BR; da Silveira DX
    J Psychopharmacol; 2014 Nov; 28(11):993-1000. PubMed ID: 25271214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A preliminary investigation of ibogaine: case reports and recommendations for further study.
    Sheppard SG
    J Subst Abuse Treat; 1994; 11(4):379-85. PubMed ID: 7966509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic plasticity and the energy economizing effect of ibogaine, the principal alkaloid of Tabernanthe iboga.
    Paškulin R; Jamnik P; Danevčič T; Koželj G; Krašovec R; Krstić-Milošević D; Blagojević D; Strukelj B
    J Ethnopharmacol; 2012 Aug; 143(1):319-24. PubMed ID: 22751004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats.
    Rho B; Glick SD
    Neuroreport; 1998 May; 9(7):1283-5. PubMed ID: 9631413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatalities after taking ibogaine in addiction treatment could be related to sudden cardiac death caused by autonomic dysfunction.
    Maas U; Strubelt S
    Med Hypotheses; 2006; 67(4):960-4. PubMed ID: 16698188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Underground ibogaine use for the treatment of substance use disorders: A qualitative analysis of subjective experiences.
    Rodríguez-Cano BJ; Kohek M; Ona G; Alcázar-Córcoles MÁ; Dos Santos RG; Hallak JEC; Bouso JC
    Drug Alcohol Rev; 2023 Feb; 42(2):401-414. PubMed ID: 36456173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients.
    Knuijver T; Ter Heine R; Schellekens AFA; Heydari P; Lucas L; Westra S; Belgers M; van Oosteren T; Verkes RJ; Kramers C
    J Psychopharmacol; 2024 May; 38(5):481-488. PubMed ID: 38519421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The anti-addiction drug ibogaine and the heart: a delicate relation.
    Koenig X; Hilber K
    Molecules; 2015 Jan; 20(2):2208-28. PubMed ID: 25642835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification.
    Davis AK; Renn E; Windham-Herman AM; Polanco M; Barsuglia JP
    J Psychoactive Drugs; 2018; 50(4):287-297. PubMed ID: 30020025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca].
    Szabó A; Kazai A; Frecska E; Brys Z
    Neuropsychopharmacol Hung; 2015 Sep; 17(3):120-8. PubMed ID: 26485742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study.
    Knuijver T; Schellekens A; Belgers M; Donders R; van Oosteren T; Kramers K; Verkes R
    Addiction; 2022 Jan; 117(1):118-128. PubMed ID: 33620733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observations on treatment with ibogaine.
    Luciano D
    Am J Addict; 1998; 7(1):89-90. PubMed ID: 9522011
    [No Abstract]   [Full Text] [Related]  

  • 37. Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature.
    Mosca A; Chiappini S; Miuli A; Mancusi G; Santovito MC; Di Carlo F; Pettorruso M; Corkery JM; Canessa C; Martinotti G; Di Giannantonio M
    Curr Neuropharmacol; 2023; 21(11):2178-2194. PubMed ID: 36263479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effects of Ibogaine on Uterine Smooth Muscle Contractions: Relation to the Activity of Antioxidant Enzymes.
    Oreščanin-Dušić Z; Tatalović N; Vidonja-Uzelac T; Nestorov J; Nikolić-Kokić A; Mijušković A; Spasić M; Paškulin R; Bresjanac M; Blagojević D
    Oxid Med Cell Longev; 2018; 2018():5969486. PubMed ID: 29599898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. For heroin addicts, a bizarre remedy. Lack of cure spurs interest in an exotic shrub.
    Koerner BI
    US News World Rep; 1999 Dec; 127(22):82. PubMed ID: 10724810
    [No Abstract]   [Full Text] [Related]  

  • 40. Addiction research. Ibogaine therapy: a 'vast, uncontrolled experiment'.
    Vastag B
    Science; 2005 Apr; 308(5720):345-6. PubMed ID: 15831735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.